Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Changes in the NFκB and E-cadherin expression are associated to diabetic nephropathy inPsammomys obesus.

Aroune D, Libdiri F, Leboucher S, Maouche B, Marco S, El-Aoufi S.

Saudi J Biol Sci. 2017 May;24(4):843-850. doi: 10.1016/j.sjbs.2016.05.009. Epub 2016 May 18.

2.
3.

Tumor suppression in mice lacking GABARAP, an Atg8/LC3 family member implicated in autophagy, is associated with alterations in cytokine secretion and cell death.

Salah FS, Ebbinghaus M, Muley VY, Zhou Z, Al-Saadi KR, Pacyna-Gengelbach M, O'Sullivan GA, Betz H, König R, Wang ZQ, Bräuer R, Petersen I.

Cell Death Dis. 2016 Apr 28;7:e2205. doi: 10.1038/cddis.2016.93.

4.

Elevated NIBP/TRAPPC9 mediates tumorigenesis of cancer cells through NFκB signaling.

Zhang Y, Liu S, Wang H, Yang W, Li F, Yang F, Yu D, Ramsey FV, Tuszyski GP, Hu W.

Oncotarget. 2015 Mar 20;6(8):6160-78.

6.

Essential oils and their constituents as anticancer agents: a mechanistic view.

Gautam N, Mantha AK, Mittal S.

Biomed Res Int. 2014;2014:154106. doi: 10.1155/2014/154106. Epub 2014 Jun 9. Review.

7.

SERMs attenuate estrogen-induced malignant transformation of human mammary epithelial cells by upregulating detoxification of oxidative metabolites.

Hemachandra LP, Patel H, Chandrasena RE, Choi J, Piyankarage SC, Wang S, Wang Y, Thayer EN, Scism RA, Michalsen BT, Xiong R, Siklos MI, Bolton JL, Thatcher GR.

Cancer Prev Res (Phila). 2014 May;7(5):505-15. doi: 10.1158/1940-6207.CAPR-13-0296. Epub 2014 Mar 5.

8.

Suppression of inflammatory cascade is implicated in methyl amooranin-mediated inhibition of experimental mammary carcinogenesis.

Mandal A, Bhatia D, Bishayee A.

Mol Carcinog. 2014 Dec;53(12):999-1010. doi: 10.1002/mc.22067. Epub 2013 Jul 12.

9.

Characterization of T-cell responses against IκBα in cancer patients.

Munir S, Frøsig TM, Hansen M, Svane IM, Andersen MH.

Oncoimmunology. 2012 Nov 1;1(8):1290-1296.

10.

Similar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies.

Perrot-Applanat M, Vacher S, Toullec A, Pelaez I, Velasco G, Cormier F, Saad Hel S, Lidereau R, Baud V, Bièche I.

PLoS One. 2011;6(7):e21589. doi: 10.1371/journal.pone.0021589. Epub 2011 Jul 6.

11.

Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2.

Antoon JW, White MD, Slaughter EM, Driver JL, Khalili HS, Elliott S, Smith CD, Burow ME, Beckman BS.

Cancer Biol Ther. 2011 Apr 1;11(7):678-89. Epub 2011 Apr 1.

12.

Mcs5c: a mammary carcinoma susceptibility locus located in a gene desert that associates with tenascin C expression.

Veillet AL, Haag JD, Remfert JL, Meilahn AL, Samuelson DJ, Gould MN.

Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. doi: 10.1158/1940-6207.CAPR-10-0187.

13.

Rationale for possible targeting of histone deacetylase signaling in cancer diseases with a special reference to pancreatic cancer.

Ouaïssi M, Giger U, Sielezneff I, Pirrò N, Sastre B, Ouaissi A.

J Biomed Biotechnol. 2011;2011:315939. doi: 10.1155/2011/315939. Epub 2010 Oct 25. Review.

14.

Modification of cysteine 179 of IkappaBalpha kinase by nimbolide leads to down-regulation of NF-kappaB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents.

Gupta SC, Prasad S, Reuter S, Kannappan R, Yadav VR, Ravindran J, Hema PS, Chaturvedi MM, Nair M, Aggarwal BB.

J Biol Chem. 2010 Nov 12;285(46):35406-17. doi: 10.1074/jbc.M110.161984. Epub 2010 Sep 9. Erratum in: J Biol Chem. 2012 Apr 6;287(15):12152.

15.

Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products.

Harikumar KB, Sung B, Tharakan ST, Pandey MK, Joy B, Guha S, Krishnan S, Aggarwal BB.

Mol Cancer Res. 2010 May;8(5):751-61. doi: 10.1158/1541-7786.MCR-09-0565. Epub 2010 May 11.

16.

BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells.

Nehra R, Riggins RB, Shajahan AN, Zwart A, Crawford AC, Clarke R.

FASEB J. 2010 Jun;24(6):2040-55. doi: 10.1096/fj.09-138305. Epub 2010 Feb 12.

17.

Mechanisms of the epithelial-mesenchymal transition by TGF-beta.

Wendt MK, Allington TM, Schiemann WP.

Future Oncol. 2009 Oct;5(8):1145-68. doi: 10.2217/fon.09.90. Review.

18.

Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

Clarke R, Shajahan AN, Riggins RB, Cho Y, Crawford A, Xuan J, Wang Y, Zwart A, Nehra R, Liu MC.

J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):8-20.

19.

Overexpression of OLC1, cigarette smoke, and human lung tumorigenesis.

Yuan J, Ma J, Zheng H, Shi T, Sun W, Zhang Q, Lin D, Zhang K, He J, Mao Y, Gao X, Gao P, Han N, Fu G, Xiao T, Gao Y, Ma D, Cheng S.

J Natl Cancer Inst. 2008 Nov 19;100(22):1592-605. doi: 10.1093/jnci/djn379. Epub 2008 Nov 11.

20.

Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity.

Lu S, Becker KA, Hagen MJ, Yan H, Roberts AL, Mathews LA, Schneider SS, Siegelmann HT, MacBeth KJ, Tirrell SM, Blanchard JL, Jerry DJ.

Endocrinology. 2008 Oct;149(10):4809-20. doi: 10.1210/en.2008-0035. Epub 2008 Jun 12.

Supplemental Content

Support Center